U.S. Regulation of Stem Cells as Medical Products

Premarketing approval by the federal government should ensure not only safety, but efficacy as well. A recent decision by a U.S. District Court judge could have profound implications for the increasing number of U.S. clinics that advertise putative “stem cell treatments” for a wide range of clinical...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Science (American Association for the Advancement of Science) 2012-12, Vol.338 (6112), p.1296-1297
Hauptverfasser:	Sipp, Douglas, Turner, Leigh
Format:	Artikel
Sprache:	eng
Schlagworte:	Advertising restrictions Biological products Biomedical research Classification Control Court rulings Criteria Drug regulation Drugs Federal court decisions Federal district courts Federal regulation Government regulation Government regulations Interstate commerce Medical services Mesenchymal stem cells Physiological regulation Pluripotent stem cells POLICY FORUM Regulatory agencies Stem cells Wall Street
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!